Novo Nordisk A/S (NONOF) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 1 Strong Buy, 17 Buy, 4 Hold, 3 Sell.
NONOF Analyst Ratings
Buy
25
Ratings
18 Buy
4 Hold
3 Sell
Based on 25 analysts giving stock ratings to Novo Nordisk A/S in the past 3 months